Daewon Pharm. Co., Ltd. is a state-of-the-art pharmaceutical company that has achieved success in commercializing Pelubi tab.,(Pelubiprofen) the 12th new drug approved by Korean Food and Drug Administration. Daewon has over 100 items of superb products developed by intensive investments on research and development. Now, Daewon Pharm. Co.,Ltd. seeks to leap forward and become a world-class global pharmaceutical company that improves human health based on advanced technologies and global expertise.